English

Teladoc Health, Inc.

EDGAR

TDOC Quarterly report (10-Q) · filed 2026-10-29

Annual consolidated revenue for 2025: about USD 2.53B, using the latest reported figures. The previous period, 2024, was about USD 2.57B.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

605 million USD

2026 Q3 · USD

Exact inputs and evidence

Revenue: 605102000 USD Source

Operating margin

-4.64%

2026 Q3 · %

Exact inputs and evidence

Operating Income: -28099000 USD Source
Revenue: 605102000 USD Source

Operating cash flow

106 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 180636000 USD Source
Operating Cash Flow: 74178000 USD Source

Free cash flow

105 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 180636000 USD Source
Operating Cash Flow: 74178000 USD Source
Capital Expenditure: 3802000 USD Source
Capital Expenditure: 2588000 USD Source

Cash and cash equivalents: 850 million USD 2026-09-30 Source
Exact value

849909000 USD
Long-term debt including current maturities: 42.4 million Unit12 2017-03-31 Source
Exact value

42434000 Unit12
Shares outstanding: 182 million shares 2026-09-30 Source
Exact value

182254430 shares

Reported share-count change

2.77% · 4.9 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

177349640 shares · 2025-09-30· Source
182254430 shares · 2026-09-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-29.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 5 of 11 periods available· newest 2025-12-31
Operating income: 5 of 11 periods available· newest 2025-12-31
Net income: 5 of 11 periods available· newest 2025-12-31
Operating cash flow: 5 of 11 periods available· newest 2025-12-31
Capital expenditure: 5 of 11 periods available· newest 2025-12-31
Total assets: 4 of 11 periods available· newest 2025-12-31
Total liabilities: 3 of 11 periods available· newest 2025-12-31
Current assets: 4 of 11 periods available· newest 2025-12-31
Current liabilities: 4 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2016-12-31
Shares outstanding: 4 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-1.5%

Prior period

USD 2.57 billion

2024-01-01 – 2024-12-31
Current period

USD 2.53 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

2529977000 − 2569574000 = -39597000 USD

2569574000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
2529977000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Teladoc Health, Inc. · 2025-12-31 Teladoc Health, Inc. (edgar:1477449) Year-over-year change in Revenue: -39597000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2529977000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#2306848 Filing: 000147744926000012 Input fundies:Revenue: 2569574000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#2332337 Filing: 000147744926000012
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 800.92 million

Prior period

−USD 1 billion

2024-01-01 – 2024-12-31
Current period

−USD 200.32 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-200322000 − -1001245000 = 800923000 USD

-1001245000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-200322000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Teladoc Health, Inc. · 2025-12-31 Teladoc Health, Inc. (edgar:1477449) Year-over-year change in Net income: 800923000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -200322000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#2327730 Filing: 000147744926000012 Input fundies:NetIncome: -1001245000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#2353240 Filing: 000147744926000012
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+0.2%

Prior period

USD 293.68 million

2024-01-01 – 2024-12-31
Current period

USD 294.36 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

294357000 − 293680000 = 677000 USD

293680000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
294357000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Teladoc Health, Inc. · 2025-12-31 Teladoc Health, Inc. (edgar:1477449) Year-over-year change in Operating cash flow: 677000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 294357000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1433373 Filing: 000147744926000012 Input fundies:OperatingCashFlow: 293680000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1434020 Filing: 000147744926000012
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-17.6%

Prior period

USD 10.79 million

2024-01-01 – 2024-12-31
Current period

USD 8.89 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

8893000 − 10790000 = -1897000 USD

10790000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
8893000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Teladoc Health, Inc. · 2025-12-31 Teladoc Health, Inc. (edgar:1477449) Year-over-year change in Capital expenditure: -1897000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 8893000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1436086 Filing: 000147744926000012 Input fundies:CapitalExpenditure: 10790000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1436675 Filing: 000147744926000012
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 2.53 billion 100% of revenue
Operating costs Derived USD 2.79 billion 110% of revenue
Operating income −USD 262.96 million −10% of revenue
Tax, interest and other Derived −USD 62.63 million −2.5% of revenue
Net income −USD 200.32 million −7.9% of revenue

Cash

Operating cash flow USD 294.36 million 12% of revenue
Capital expenditure USD 8.89 million 0.4% of revenue
Free cash flow Derived USD 285.46 million 11% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2021 Operating loss: operating costs were 113% of revenue.
2022 Operating loss: operating costs were 667% of revenue.
2023 Operating loss: operating costs were 110% of revenue.
2024 Operating loss: operating costs were 140% of revenue.
2025 Operating loss: operating costs were 110% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2021 2021-01-01 – 2021-12-31	2032707000	2298338000 Derived	-265631000	163162000 Derived	-428793000	185456000 Derived	Source 2021-01-01 – 2021-12-31: 2032707000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -265631000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -428793000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 193990000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 8534000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	2406840000	16060054000 Derived	-13653214000	6317000 Derived	-13659531000	172812000 Derived	Source 2022-01-01 – 2022-12-31: 2406840000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -13653214000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -13659531000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 189292000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 16480000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	2602415000	2850968000 Derived	-248553000	-28185000 Derived	-220368000	338557000 Derived	Source 2023-01-01 – 2023-12-31: 2602415000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -248553000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -220368000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: 350021000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 11464000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	2569574000	3590460000 Derived	-1020886000	-19641000 Derived	-1001245000	282890000 Derived	Source 2024-01-01 – 2024-12-31: 2569574000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -1020886000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -1001245000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: 293680000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 10790000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	2529977000	2792932000 Derived	-262955000	-62633000 Derived	-200322000	285464000 Derived	Source 2025-01-01 – 2025-12-31: 2529977000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -262955000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -200322000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: 294357000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 8893000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.5B 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Revenue	2032707000	Revenue: 2032707000 Open source
20222022-12-31	Revenue	2406840000	Revenue: 2406840000 Open source
20232023-12-31	Revenue	2602415000	Revenue: 2602415000 Open source
20242024-12-31	Revenue	2569574000	Revenue: 2569574000 Open source
20252025-12-31	Revenue	2529977000	Revenue: 2529977000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-1.5% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Year over year	No prior comparable period	Revenue: 2032707000 Open source
20222022-12-31	Year over year	18.4%	Revenue: 2406840000 Open source Revenue: 2032707000 Open source
20232023-12-31	Year over year	8.1%	Revenue: 2602415000 Open source Revenue: 2406840000 Open source
20242024-12-31	Year over year	-1.3%	Revenue: 2569574000 Open source Revenue: 2602415000 Open source
20252025-12-31	Year over year	-1.5%	Revenue: 2529977000 Open source Revenue: 2569574000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -10.4% 2025

Net margin -7.9% 2025

Free cash flow margin 11.3% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20212021-12-31	Operating margin	-13.1%	Operating Income: -265631000 Open source Revenue: 2032707000 Open source
20222022-12-31	Operating margin	-567.3%	Operating Income: -13653214000 Open source Revenue: 2406840000 Open source
20232023-12-31	Operating margin	-9.6%	Operating Income: -248553000 Open source Revenue: 2602415000 Open source
20242024-12-31	Operating margin	-39.7%	Operating Income: -1020886000 Open source Revenue: 2569574000 Open source
20252025-12-31	Operating margin	-10.4%	Operating Income: -262955000 Open source Revenue: 2529977000 Open source
20212021-12-31	Net margin	-21.1%	Net Income: -428793000 Open source Revenue: 2032707000 Open source
20222022-12-31	Net margin	-567.5%	Net Income: -13659531000 Open source Revenue: 2406840000 Open source
20232023-12-31	Net margin	-8.5%	Net Income: -220368000 Open source Revenue: 2602415000 Open source
20242024-12-31	Net margin	-39%	Net Income: -1001245000 Open source Revenue: 2569574000 Open source
20252025-12-31	Net margin	-7.9%	Net Income: -200322000 Open source Revenue: 2529977000 Open source
20212021-12-31	Free cash flow margin	9.1%	Revenue: 2032707000 Open source Operating Cash Flow: 193990000 Open source Capital Expenditure: 8534000 Open source
20222022-12-31	Free cash flow margin	7.2%	Revenue: 2406840000 Open source Operating Cash Flow: 189292000 Open source Capital Expenditure: 16480000 Open source
20232023-12-31	Free cash flow margin	13%	Revenue: 2602415000 Open source Operating Cash Flow: 350021000 Open source Capital Expenditure: 11464000 Open source
20242024-12-31	Free cash flow margin	11%	Revenue: 2569574000 Open source Operating Cash Flow: 293680000 Open source Capital Expenditure: 10790000 Open source
20252025-12-31	Free cash flow margin	11.3%	Revenue: 2529977000 Open source Operating Cash Flow: 294357000 Open source Capital Expenditure: 8893000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 294.4M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Operating cash flow	193990000	Operating Cash Flow: 193990000 Open source
20222022-12-31	Operating cash flow	189292000	Operating Cash Flow: 189292000 Open source
20232023-12-31	Operating cash flow	350021000	Operating Cash Flow: 350021000 Open source
20242024-12-31	Operating cash flow	293680000	Operating Cash Flow: 293680000 Open source
20252025-12-31	Operating cash flow	294357000	Operating Cash Flow: 294357000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 285.5M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20212021-12-31	Free cash flow	185456000	Operating Cash Flow: 193990000 Open source Capital Expenditure: 8534000 Open source
20222022-12-31	Free cash flow	172812000	Operating Cash Flow: 189292000 Open source Capital Expenditure: 16480000 Open source
20232023-12-31	Free cash flow	338557000	Operating Cash Flow: 350021000 Open source Capital Expenditure: 11464000 Open source
20242024-12-31	Free cash flow	282890000	Operating Cash Flow: 293680000 Open source Capital Expenditure: 10790000 Open source
20252025-12-31	Free cash flow	285464000	Operating Cash Flow: 294357000 Open source Capital Expenditure: 8893000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

51.5% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2021-12-31	Liabilities / assets	Not reported	No source recorded
2022-12-31	Liabilities / assets	Not reported	Total Assets: 4345355000 Open source
20232023-12-31	Liabilities / assets	47%	Total Liabilities: 2066296000 Open source Total Assets: 4392369000 Open source
20242024-12-31	Liabilities / assets	57.6%	Total Liabilities: 2025445000 Open source Total Assets: 3516524000 Open source
20252025-12-31	Liabilities / assets	51.5%	Total Liabilities: 1472594000 Open source Total Assets: 2858300000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.77× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2021-12-31	Current assets / current liabilities	Not reported	No source recorded
20222022-12-31	Current assets / current liabilities	3.29×	Current Assets: 1315388000 Open source Current Liabilities: 399769000 Open source
20232023-12-31	Current assets / current liabilities	3.54×	Current Assets: 1489048000 Open source Current Liabilities: 420616000 Open source
20242024-12-31	Current assets / current liabilities	1.77×	Current Assets: 1663907000 Open source Current Liabilities: 941535000 Open source
20252025-12-31	Current assets / current liabilities	2.77×	Current Assets: 1119129000 Open source Current Liabilities: 404738000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2021 2021-01-01 – 2021-12-31	−USD 428.79 million Exact value Exact value: -428793000 USD 2021-01-01 – 2021-12-31: -428793000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Teladoc Health, Inc. · 2021-12-31 Teladoc Health, Inc. (edgar:1477449) Net Income: -428793000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -428793000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000023/tdoc-20231231.htm#2239170 Filing: 000147744924000023 The citation records this snapshot. The page link may show a newer release later.	USD 193.99 million Exact value Exact value: 193990000 USD 2021-01-01 – 2021-12-31: 193990000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Teladoc Health, Inc. · 2021-12-31 Teladoc Health, Inc. (edgar:1477449) Operating Cash Flow: 193990000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 193990000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000023/tdoc-20231231.htm#1406632 Filing: 000147744924000023 The citation records this snapshot. The page link may show a newer release later.	USD 8.53 million Exact value Exact value: 8534000 USD 2021-01-01 – 2021-12-31: 8534000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Teladoc Health, Inc. · 2021-12-31 Teladoc Health, Inc. (edgar:1477449) Capital Expenditure: 8534000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8534000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000023/tdoc-20231231.htm#1409256 Filing: 000147744924000023 The citation records this snapshot. The page link may show a newer release later.	USD 185.46 million Calculation and evidence 193990000 − 8534000 USD Exact free cash flow: 185456000 USD 2021-01-01 – 2021-12-31: 193990000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 8534000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Teladoc Health, Inc. · 2021-12-31 Teladoc Health, Inc. (edgar:1477449) Free cash flow: 185456000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 193990000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000023/tdoc-20231231.htm#1406632 Filing: 000147744924000023 Input fundies:CapitalExpenditure: 8534000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744924000023/tdoc-20231231.htm#1409256 Filing: 000147744924000023 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 13.66 billion Exact value Exact value: -13659531000 USD 2022-01-01 – 2022-12-31: -13659531000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Teladoc Health, Inc. · 2022-12-31 Teladoc Health, Inc. (edgar:1477449) Net Income: -13659531000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13659531000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744925000005/tdoc-20241231.htm#2286637 Filing: 000147744925000005 The citation records this snapshot. The page link may show a newer release later.	USD 189.29 million Exact value Exact value: 189292000 USD 2022-01-01 – 2022-12-31: 189292000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Teladoc Health, Inc. · 2022-12-31 Teladoc Health, Inc. (edgar:1477449) Operating Cash Flow: 189292000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 189292000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744925000005/tdoc-20241231.htm#1421855 Filing: 000147744925000005 The citation records this snapshot. The page link may show a newer release later.	USD 16.48 million Exact value Exact value: 16480000 USD 2022-01-01 – 2022-12-31: 16480000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Teladoc Health, Inc. · 2022-12-31 Teladoc Health, Inc. (edgar:1477449) Capital Expenditure: 16480000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16480000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744925000005/tdoc-20241231.htm#1424479 Filing: 000147744925000005 The citation records this snapshot. The page link may show a newer release later.	USD 172.81 million Calculation and evidence 189292000 − 16480000 USD Exact free cash flow: 172812000 USD 2022-01-01 – 2022-12-31: 189292000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 16480000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Teladoc Health, Inc. · 2022-12-31 Teladoc Health, Inc. (edgar:1477449) Free cash flow: 172812000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 189292000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744925000005/tdoc-20241231.htm#1421855 Filing: 000147744925000005 Input fundies:CapitalExpenditure: 16480000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744925000005/tdoc-20241231.htm#1424479 Filing: 000147744925000005 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 220.37 million Exact value Exact value: -220368000 USD 2023-01-01 – 2023-12-31: -220368000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Teladoc Health, Inc. · 2023-12-31 Teladoc Health, Inc. (edgar:1477449) Net Income: -220368000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -220368000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#2379519 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.	USD 350.02 million Exact value Exact value: 350021000 USD 2023-01-01 – 2023-12-31: 350021000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Teladoc Health, Inc. · 2023-12-31 Teladoc Health, Inc. (edgar:1477449) Operating Cash Flow: 350021000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 350021000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1434668 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.	USD 11.46 million Exact value Exact value: 11464000 USD 2023-01-01 – 2023-12-31: 11464000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Teladoc Health, Inc. · 2023-12-31 Teladoc Health, Inc. (edgar:1477449) Capital Expenditure: 11464000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11464000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1437266 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.	USD 338.56 million Calculation and evidence 350021000 − 11464000 USD Exact free cash flow: 338557000 USD 2023-01-01 – 2023-12-31: 350021000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 11464000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Teladoc Health, Inc. · 2023-12-31 Teladoc Health, Inc. (edgar:1477449) Free cash flow: 338557000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 350021000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1434668 Filing: 000147744926000012 Input fundies:CapitalExpenditure: 11464000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1437266 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 1 billion Exact value Exact value: -1001245000 USD 2024-01-01 – 2024-12-31: -1001245000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Teladoc Health, Inc. · 2024-12-31 Teladoc Health, Inc. (edgar:1477449) Net Income: -1001245000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1001245000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#2353240 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.	USD 293.68 million Exact value Exact value: 293680000 USD 2024-01-01 – 2024-12-31: 293680000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Teladoc Health, Inc. · 2024-12-31 Teladoc Health, Inc. (edgar:1477449) Operating Cash Flow: 293680000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 293680000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1434020 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.	USD 10.79 million Exact value Exact value: 10790000 USD 2024-01-01 – 2024-12-31: 10790000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Teladoc Health, Inc. · 2024-12-31 Teladoc Health, Inc. (edgar:1477449) Capital Expenditure: 10790000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10790000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1436675 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.	USD 282.89 million Calculation and evidence 293680000 − 10790000 USD Exact free cash flow: 282890000 USD 2024-01-01 – 2024-12-31: 293680000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 10790000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Teladoc Health, Inc. · 2024-12-31 Teladoc Health, Inc. (edgar:1477449) Free cash flow: 282890000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 293680000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1434020 Filing: 000147744926000012 Input fundies:CapitalExpenditure: 10790000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1436675 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 200.32 million Exact value Exact value: -200322000 USD 2025-01-01 – 2025-12-31: -200322000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Teladoc Health, Inc. · 2025-12-31 Teladoc Health, Inc. (edgar:1477449) Net Income: -200322000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -200322000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#2327730 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.	USD 294.36 million Exact value Exact value: 294357000 USD 2025-01-01 – 2025-12-31: 294357000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Teladoc Health, Inc. · 2025-12-31 Teladoc Health, Inc. (edgar:1477449) Operating Cash Flow: 294357000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 294357000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1433373 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.	USD 8.89 million Exact value Exact value: 8893000 USD 2025-01-01 – 2025-12-31: 8893000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Teladoc Health, Inc. · 2025-12-31 Teladoc Health, Inc. (edgar:1477449) Capital Expenditure: 8893000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8893000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1436086 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.	USD 285.46 million Calculation and evidence 294357000 − 8893000 USD Exact free cash flow: 285464000 USD 2025-01-01 – 2025-12-31: 294357000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 8893000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Teladoc Health, Inc. · 2025-12-31 Teladoc Health, Inc. (edgar:1477449) Free cash flow: 285464000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:22:49Z Snapshot: 8b8a3a5d4e31e0dfd99b108e539dbf7ab7a42363b61f2062a453ef3e38db973b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1477449?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 294357000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1433373 Filing: 000147744926000012 Input fundies:CapitalExpenditure: 8893000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/tdoc-20251231.htm#1436086 Filing: 000147744926000012 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

78 filings · 5,466 latest values · 5,466 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001477449, 1477449, TDOC, edgar:1477449

Also known as TELADOC HEALTH, INC., TELADOC HEALTH, INC., Teladoc Health, Inc., Teladoc Health, Inc., Teladoc, Inc.

Teladoc Health, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation